{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:36:09Z","timestamp":1787697369947,"version":"build-2784847793"},"posted":{"date-parts":[[2025,11,13]]},"group-title":"Neuroscience","reference-count":39,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"NIH\/NIDA Intramural Research Program"},{"name":"The State of New Jersey - Camden Opioid Research Initiative"},{"name":"Rowan University- Francis Lax Faculty Development Fund"},{"name":"Rowan University- startup funds"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,11,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Rationale<\/jats:title>\n                  <jats:p>\n                    One of the current models for drug (opioid) user typology employs differential access conditions to categorize takers into short-access and long-access groups (ShA, LgA) with the rationale that these groups represent distinct opioid user phenotypes. However, with the idea that differential vulnerabilities to opioid effects are already present prior to experimenter assignment into these groups, it is unclear that these groups represent distinct opioid user types. To clarify this, we have developed a method that includes principal component analysis-gaussian mixtures model clustering of variables derived from a new CENTERED (\n                    <jats:underline>C<\/jats:underline>\n                    umulative\n                    <jats:underline>E<\/jats:underline>\n                    xperience-\n                    <jats:underline>N<\/jats:underline>\n                    ormalized\n                    <jats:underline>T<\/jats:underline>\n                    ime-\n                    <jats:underline>E<\/jats:underline>\n                    ffect on\n                    <jats:underline>R<\/jats:underline>\n                    esponse as an\n                    <jats:underline>E<\/jats:underline>\n                    xponential\n                    <jats:underline>D<\/jats:underline>\n                    ecay structure) model. The goal of this study was to utilize CENTERED clustering to test the hypothesis that ShA and LgA groups defined by the experimenter via random assignment are composed of mixtures of individuals that belong to distinct opioid user types.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We reanalyzed data from a previous study in which the experimenter assigned male Sprague Dawley rats (n = 30) self-administering 0.1 mg\/kg\/infusion oxycodone for 20 days into ShA (3h-access) and LgA (9h-access). We conducted CENTERED clustering on all takers, irrespective of assigned group(s) to determine if the experimenter-assigned groups included mixtures of individuals from groups (opioid user types) identified via CENTERED clustering.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>CENTERED clustering revealed that ShA and LgA groups consisted of mixtures of different opioid user types.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>CENTERED clustering revealed that experimenter-imposed grouping via differential access conditions limits our ability to identify distinct opioid user types that already exist naturally in the population.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.11.10.687622","type":"posted-content","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T17:30:39Z","timestamp":1763055039000},"source":"Crossref","is-referenced-by-count":2,"title":["A Challenge To The Assumption That Short- versus Long-Access Groups of Opioid Users Represent Distinct Phenotypes"],"prefix":"10.64898","author":[{"given":"Michael A.","family":"Giunta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indu Mithra","family":"Madhuranthakam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0764-3992","authenticated-orcid":false,"given":"Martin O.","family":"Job","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2025111414250802000_2025.11.10.687622v1.1","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0219717"},{"key":"2025111414250802000_2025.11.10.687622v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(99)00133-5"},{"key":"2025111414250802000_2025.11.10.687622v1.3","doi-asserted-by":"crossref","unstructured":"Allen, C. , Kuhn, B.N. , Cannella, N. , Crow, A.D. , Roberts, A.T. , Lunerti, V. , Ubaldi, M. , Hardiman, G. , Solberg Woods, L.C. , Ciccocioppo, R. , Kalivas, P.W. , Chung, D ., 2021. Network-Based Discovery of Opioid Use Vulnerability in Rats Using the Bayesian Stochastic Block Model. Front. Psychiatry 12.","DOI":"10.3389\/fpsyt.2021.745468"},{"key":"2025111414250802000_2025.11.10.687622v1.4","doi-asserted-by":"publisher","DOI":"10.1001\/JAMAPSYCHIATRY.2024.3836"},{"key":"2025111414250802000_2025.11.10.687622v1.5","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1318-z"},{"key":"2025111414250802000_2025.11.10.687622v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2019.07.030"},{"key":"2025111414250802000_2025.11.10.687622v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-021-82206-3"},{"key":"2025111414250802000_2025.11.10.687622v1.8","doi-asserted-by":"publisher","DOI":"10.25318\/82-003-X202300300001-ENG"},{"key":"2025111414250802000_2025.11.10.687622v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2008.07.012"},{"key":"2025111414250802000_2025.11.10.687622v1.10","doi-asserted-by":"publisher","DOI":"10.3389\/FNBEH.2022.1035350\/PDF"},{"key":"2025111414250802000_2025.11.10.687622v1.11","doi-asserted-by":"publisher","DOI":"10.1111\/add.13238"},{"key":"2025111414250802000_2025.11.10.687622v1.12","doi-asserted-by":"publisher","DOI":"10.1111\/ADD.15594"},{"key":"2025111414250802000_2025.11.10.687622v1.13","doi-asserted-by":"publisher","DOI":"10.1002\/CPT.3112"},{"key":"2025111414250802000_2025.11.10.687622v1.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05479-y"},{"key":"2025111414250802000_2025.11.10.687622v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/S41380-025-02922-4"},{"key":"2025111414250802000_2025.11.10.687622v1.16","doi-asserted-by":"publisher","DOI":"10.1176\/APPI.AJP.20230623"},{"key":"2025111414250802000_2025.11.10.687622v1.17","doi-asserted-by":"publisher","DOI":"10.1093\/JAMIA\/OCAD111"},{"key":"2025111414250802000_2025.11.10.687622v1.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-05850-7"},{"key":"2025111414250802000_2025.11.10.687622v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108355"},{"key":"2025111414250802000_2025.11.10.687622v1.20","doi-asserted-by":"publisher","DOI":"10.3233\/SHTI200276"},{"key":"2025111414250802000_2025.11.10.687622v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2021.103889"},{"key":"2025111414250802000_2025.11.10.687622v1.22","doi-asserted-by":"publisher","DOI":"10.1136\/BMJOPEN-2024-095645"},{"key":"2025111414250802000_2025.11.10.687622v1.23","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15520"},{"key":"2025111414250802000_2025.11.10.687622v1.24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011117.PUB3"},{"key":"2025111414250802000_2025.11.10.687622v1.25","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05618-5"},{"key":"2025111414250802000_2025.11.10.687622v1.26","doi-asserted-by":"publisher","DOI":"10.1126\/SCIADV.ABF0364"},{"key":"2025111414250802000_2025.11.10.687622v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174407"},{"key":"2025111414250802000_2025.11.10.687622v1.28","doi-asserted-by":"publisher","DOI":"10.3389\/FNINS.2020.617973"},{"key":"2025111414250802000_2025.11.10.687622v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.293"},{"key":"2025111414250802000_2025.11.10.687622v1.30","doi-asserted-by":"publisher","DOI":"10.3233\/SHTI230299"},{"key":"2025111414250802000_2025.11.10.687622v1.31","doi-asserted-by":"crossref","unstructured":"Showell, B.H. , Job, M.O. , 2024. The most significant differences between male and female rats regarding psychostimulant self-administration behavior are unrelated to biological sex.","DOI":"10.1101\/2024.11.01.621540"},{"key":"2025111414250802000_2025.11.10.687622v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsgos.2025.100519"},{"key":"2025111414250802000_2025.11.10.687622v1.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.03.019"},{"key":"2025111414250802000_2025.11.10.687622v1.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.109972"},{"key":"2025111414250802000_2025.11.10.687622v1.35","doi-asserted-by":"publisher","DOI":"10.1038\/NPP.2017.172"},{"key":"2025111414250802000_2025.11.10.687622v1.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2011.03.004"},{"key":"2025111414250802000_2025.11.10.687622v1.37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1653356"},{"key":"2025111414250802000_2025.11.10.687622v1.38","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.3390\/ijms26157356","article-title":"Escalated Oxycodone Self-Administration Is Associated with Activation of Specific Gene Networks in the Rat Dorsal Striatum","volume":"26","year":"2025","journal-title":"Int. J. Mol. Sci"},{"key":"2025111414250802000_2025.11.10.687622v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.188"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.11.10.687622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:01:02Z","timestamp":1768471262000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.11.10.687622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":39,"URL":"https:\/\/doi.org\/10.1101\/2025.11.10.687622","relation":{},"subject":[],"published":{"date-parts":[[2025,11,13]]},"subtype":"preprint"}}